| Record ID | marc_university_of_toronto/uoft.marc:4234778343:1558 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:4234778343:1558?format=raw |
LEADER: 01558cam 2200337 a 4500
005 20020505152718.3
008 020505s2001 onca b 000 0 eng d
020 $a1894620143 (print)
020 $a1894620135 (online)
039 $fcsg/csg(csg)//jv
050 4 $aRM666.Q55$bN49 2001
060 4 $aWC 202
245 00 $aNew fluoroquinolones in community-acquired pneumonia :$ba clinical and economic evaluation /$cColleen J. Metge...[et al.].
260 $aOttawa, Ont. :$bCanadian Coordinating Office for Health Technology Assessment,$c[2001]
300 $ax, 75 p. :$bill. ;$c28 cm.
490 1 $aTechnology report ;$vissue 20
500 $a"November 2001".
504 $aIncludes bibliographical references (p. 34-40).
650 2 $aFluoroquinolones$xeconomics.
650 2 $aFluoroquinolones$xtherapeutic use.
650 0 $aPneumonia$xChemotherapy.
650 2 $aPneumonia$xdrug therapy.
650 0 $aQuinolone antibacterial agents$xTherapeutic use$xCost effectiveness.
650 0 $aQuinolone antibacterial agents$xTherapeutic use.
650 2 $aRandomized Controlled Trials.
700 1 $aMetge, Colleen Jane
710 2 $aCanadian Coordinating Office for Health Technology Assessment.
830 0 $aTechnology report (Canadian Coordinating Office for Health Technology Assessment) ;$vissue 20.
948 $a05/06/2002$b07/07/2002
949 $aRC771 .N48 2001$wLC$c1$i31761054742051$d5/12/2006$e17/10/2006$lSTACKS$mGERSTEIN$n5$q1$rY$sY$tBOOK$u23/5/2002
949 $aRC771 .N48 2001$wLC$c2$i31761054448642$lSTACKS$mGERSTEIN$rY$sY$tBOOK$u3/6/2002